10X Genomics, Inc. (TXG)
93.50
+4.74
(+5.34%)
USD |
NASDAQ |
Oct 02, 16:00
94.00
+0.50
(+0.53%)
Pre-Market: 20:00
10X Genomics Profit Margin (Quarterly) : -11.87% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.87% |
| March 31, 2026 | -8.93% |
| December 31, 2025 | -9.79% |
| September 30, 2025 | -18.44% |
| June 30, 2025 | 19.97% |
| March 31, 2025 | -22.18% |
| December 31, 2024 | -29.71% |
| September 30, 2024 | -23.58% |
| June 30, 2024 | -24.75% |
| March 31, 2024 | -42.52% |
| December 31, 2023 | -26.61% |
| September 30, 2023 | -60.52% |
| June 30, 2023 | -42.51% |
| March 31, 2023 | -37.79% |
| December 31, 2022 | -11.02% |
| September 30, 2022 | -31.98% |
| June 30, 2022 | -56.24% |
| March 31, 2022 | -37.04% |
| December 31, 2021 | -12.85% |
| Date | Value |
|---|---|
| September 30, 2021 | -13.70% |
| June 30, 2021 | -9.54% |
| March 31, 2021 | -10.92% |
| December 31, 2020 | -370.3% |
| September 30, 2020 | -91.69% |
| June 30, 2020 | -93.62% |
| March 31, 2020 | -29.40% |
| December 31, 2019 | -9.48% |
| September 30, 2019 | -15.69% |
| June 30, 2019 | -19.49% |
| March 31, 2019 | -6.79% |
| December 31, 2018 | -149.4% |
| September 30, 2018 | -41.92% |
| June 30, 2018 | -18.66% |
| March 31, 2018 | -57.26% |
| December 31, 2017 | -16.33% |
| September 30, 2017 | -24.49% |
| June 30, 2017 | -25.19% |
| March 31, 2017 | -52.29% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | -29.61% |
| Tempus AI, Inc. | 1.48% |
| Personalis, Inc. | -141.7% |
| Alamar Biosciences, Inc. (California) | -44.85% |
| Beam Therapeutics, Inc. | -25.04K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.40% |
| Return on Assets | -7.37% |
| Return on Invested Capital | -8.51% |
| Gross Profit Margin (Quarterly) | 74.36% |
| Operating Margin (Quarterly) | -15.20% |
| Return on Net Operating Assets | -16.73% |